E2F7 and breast carcinoma: Further analysis of its targets and upstream regulatory mechanism showed that highly expressed E2F7 represses miR-15a/16 expression, which then up-regulates Bcl-2 and Cyclin E1 to induce tamoxifen resistance of breast cancer cells.